MyFinsight
Home
Blog
About
Back
Income Statement
Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. (EVFM)
source: myfinsight.com
Net loss
attributable to common...
-$11,144K
(-524.31%↓ Y/Y)
Net loss
-$11,036K
(-518.61%↓ Y/Y)
Convertible and redeemable
preferred stock deemed...
$108K
(10900.00%↑ Y/Y)
Loss before income
tax expense
-$11,036K
(-521.05%↓ Y/Y)
Total other income
(expense), net
-$8,547K
(-1524.90%↓ Y/Y)
Loss from operations
-$2,489K
(-98.96%↓ Y/Y)
Interest income
$3K
(50.00%↑ Y/Y)
Product sales, net
$2,633K
(-45.43%↓ Y/Y)
Change in fair value of
financial instruments
-$5,745K
(-4387.31%↓ Y/Y)
Loss on debt
extinguishment
-$2,192K
Other expense, net
$613K
(-7.40%↓ Y/Y)
Total operating
expenses
$5,122K
(-15.70%↓ Y/Y)
Selling and marketing
$2,075K
(-20.95%↓ Y/Y)
General and
administrative
$1,828K
(-0.81%↓ Y/Y)
Research and
development, net
$694K
(-6.97%↓ Y/Y)
Cost of goods sold
$511K
(-32.32%↓ Y/Y)
Amortization of intangible
asset
$14K
(-86.00%↓ Y/Y)
Back